Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   539,056    

Indirect Shares

   247,533      
Direct Value   $43,131,096    

Indirect Value

   $21,938,850      
Total Shares   786,589      
Total Value   $65,069,946      


Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,680 Incyte Corp $883,876 Immunome Inc. $112,093 Biomarin Pharmaceutical Inc $42,098,718 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,680 Incyte Corp $883,876 Immunome Inc. $112,093
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -34.0%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-10 474,994 2024-05-10 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM Director 2023-11-07 7,615 0    Premium*  
* Premium Members only  

Records found :    850         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 13 of 34
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-08 4 AS $91.27 $275,598 D/D (3,000) 324,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-12 4 AS $89.12 $356,480 D/D (4,000) 325,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-04-26 4 AS $82.44 $248,640 D/D (3,000) 326,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-05-08 4 AS $82.16 $328,625 D/D (4,000) 326,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-05-09 4 AS $81.97 $327,888 D/D (4,000) 326,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-05-10 4 AS $82.52 $825,193 D/D (10,000) 326,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-10-25 4 AS $69.55 $347,750 D/D (5,000) 327,520 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-11-22 4 AS $77.60 $776,000 D/D (10,000) 327,080 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-12-26 4 AS $86.43 $259,290 D/D (3,000) 327,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-12-27 4 AS $86.16 $430,800 D/D (5,000) 327,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-01-07 4 AS $84.46 $253,380 D/D (3,000) 327,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-01-08 4 AS $84.92 $339,680 D/D (4,000) 327,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-01-14 4 AS $87.95 $703,600 D/D (8,000) 327,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-02-03 4 AS $83.50 $835,000 D/D (10,000) 328,530 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-03-09 4 AS $89.52 $895,200 D/D (10,000) 296,443 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-04-09 4 AS $79.06 $790,600 D/D (10,000) 298,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-04-27 4 AS $97.73 $1,954,600 D/D (20,000) 298,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-04-28 4 AS $97.58 $1,951,600 D/D (20,000) 298,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-05-01 4 AS $89.38 $357,520 D/D (4,000) 298,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-05-04 4 AS $88.00 $440,000 D/D (5,000) 298,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-05-08 4 AS $91.72 $1,834,400 D/D (20,000) 298,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-12-28 4 AS $88.77 $133,155 D/D (1,500) 297,052 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-12-29 4 AS $88.18 $132,270 D/D (1,500) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-01-27 4 AS $85.49 $712,388 D/D (8,333) 295,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-01-28 4 AS $82.91 $690,889 D/D (8,333) 295,552 0 -
  850  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13  14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34      
  Page 13 of 34  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us